Colorectal Cancer | Proceedings from a live event held adjunct to the 2022 Gastrointestinal Cancers Symposium

Featuring perspectives from Drs Kristen Ciombor, Cathy Eng, Pashtoon Kasi, Christopher Lieu and Alan Venook, including the following topics: Introduction (0:00) Current and Future Role of Therapies Targeting BRAF and HER2 in Metastatic Colorectal Cancer (mCRC) — Alan P Venook, MD (10:25) Integration of Immune Checkpoint Inhibitors into the Management of mCRC — Cathy Eng, MD (24:51) Selection and Sequencing of Therapy for Patients with Multiregimen-Refractory mCRC — Kristen K Ciombor, MD, MSCI (47:59) Other Considerations in the Management of Colorectal Cancer; Promising Investigational Strategies — Christopher Lieu, MD(1:11:40) CME information and select publications